Commentary on: "Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide" - PubMed (original) (raw)

Comment

. 2017 Jul;10(4):240-241.

doi: 10.1111/cts.12476. Epub 2017 Jun 29.

Affiliations

Comment

Commentary on: "Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide"

K M Morrissey et al. Clin Transl Sci. 2017 Jul.

No abstract available

PubMed Disclaimer

Comment on

References

    1. Wienkers, L.C. & Heath, T.G. Predicting in vivo drug interactions from in vitro drug discovery data. Nat. Rev. Drug Discov. 10, 825–833 (2005). -PubMed
    1. Kusuhara, H. & Sugiyama, Y. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters. Drug Metab. Rev. 3, 539–550 (2010). -PubMed
    1. Wacher, V.J. , Wu, C.Y. & Benet, L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 3, 129–134 (1995). -PubMed
    1. Bins S., et al Influence of OATP1B1 function on the disposition of sorafenib‐β‐D‐glucuronide. Clin. Transl. Sci. (2017). https://doi.org/10.1111/cts.12458 -DOI -PMC -PubMed
    1. Iusuf, D. , van de Steeg, E. & Schinkel, A.H. Hepatocyte hopping of OATP1B substrates contributes to efficient hepatic detoxification. Clin. Pharmacol. Ther. 5, 559–562 (2012). -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources